10x Genomics: Pay

10x Genomics paid its 4 named executives $14.6M in total in FY2025 (Dec). CEO Serge Saxonov was paid $6.3M of that.

Pay$100 in the stock at the end of FY20 → $12
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Serge SaxonovChief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Eric S. WhitakerFormer Chief Legal Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Benjamin J. HindsonPresident and Chief Scientific Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Adam S. TaichChief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
2 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 7 peers with pay on file was $8.2M. The CEO of 10x Genomics was paid $6.3M, 22% below the median.

  1. 1Insulet
  2. 2Natera
  3. 3Sotera Health
  4. 4BIO-TECHNE
  5. 5Veracyte
  6. 610x Genomics
  7. 7Repligen
  8. 8Penumbra
  9. 9Azenta, Inc.Not disclosed
  10. 10CertaraNot disclosed
  11. 11Exact Sciences CorporationNot disclosed
  12. 12GoodRx Holdings, Inc.Not disclosed
  13. 13Guardant HealthNot disclosed
  14. 14HaemoneticsNot disclosed
  15. 15Inari Medical, Inc.Not disclosed
  16. 16Maravai Lifesciences Holdings, Inc.Not disclosed
  17. 17Myriad Genetics, Inc.Not disclosed
  18. 18NeoGeonomics, Inc.Not disclosed
  19. 19NovoCure LimitedNot disclosed
  20. 20iRhythm Technologies, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.